Compared to their bulk materials, nanomaterials offer a wide range of distinct physicochemical properties that are ideal for many biomedical purposes. Some of the different applications of nanomaterials within medicine include drug delivery, tissue engineering, bio-micromechanical systems (bioMEMS), biosensors, microfluidics, and diagnostics. Of these, nanomaterial-based drug delivery systems have emerged as one of the primary uses of nanotechnology within medicine.
The small size of nanomaterials is mainly responsible for their various advantageous properties. For drug delivery systems, nanomaterials have not only improved the targeting specificity of these drugs but have also improved circulation time, biodistribution, solubility, intracellular delivery, and ability to cross biological membranes. For cancer treatment purposes, nanocarriers have also been found to allow for drugs to accumulate at high levels at the tumor site.
An Overview of Inorganic Nanomaterials
Inorganic nanoparticles (INPs) have been widely studied over the past several decades for a wide variety of industrial purposes. Within the field of biomedicine, INPs have been utilized for both diagnostic and therapeutic purposes.
For example, gold nanoparticles (AuNPs) have been widely studied due to their biocompatibility and the ease of controlling their size distribution and shape, which can include spheres, nanorods, and cubes, among others. Furthermore, the surface chemistry of AuNPs can also be easily modified through conjugation with various polymers, antibodies, small-molecule therapeutics, and molecular probes.
Another prevalent type of INP includes iron oxide nanoparticles (IONPs), which have been widely used since the 1960s for diagnostic imaging and therapeutic purposes. To date, the United States Food and Drug Administration (FDA) has approved several IONPs for both therapeutic and imaging use. In particular, magnetite (Fe3O4) nanoparticles have been used as a contrast agent for magnetic resonance imaging (MRI) due to their extremely low cytotoxicity profile, magnetic responsiveness, tunability, and controlled size and surface modification.
MSNPs have also been studied for their use as stimuli-responsive drug release systems. In this application, the surface of MSNPs can be manipulated to adjust the controlled release of the encapsulated drug after a trigger reaction occurs. Some of the different medications that have been incorporated into MSNP-based drug delivery systems include vancomycin and adenosine triphosphate (ATP).
An Overview of Organic Nanomaterials
Several organic-based nanomaterials, including liposomes, micelles, and polymer nanoparticles, have been developed for drug delivery purposes.
Liposomes, for example, or a type of lipid-based nanomaterial that consists of an aqueous core surrounded by a phospholipid bilayer. This structure is therefore amphiphilic and allows for the formation of a thermodynamically stabilized vesicle. Some of the most common types of phospholipids that are often incorporated into liposomes include phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine, and phosphatidylglycerol. In addition to these phospholipids, stabilizers like cholesterol are also often incorporated into a liposome to increase their stability.
As drug delivery vehicles, liposomes have been shown to improve the permeation of hydrophilic drugs, protect peptides and other protein-based drugs against harsh conditions like the stomach’s acidity, improve the bioavailability of drugs, as well as reduce toxicity and adverse side effects. Notably, the targeting ability and rate of drug release of liposomes depend on the type of lipid incorporated into the liposome and their size, lamellarity, and surface properties.
Applications in Cancer Treatment
Both INPs and organic nanoparticles have been widely studied for their use as drug delivery vehicles for anticancer drugs. For example, AuNPs and IONPs and their combination have been explored for HER2 receptor-based targeting of drugs for the treatment of breast cancer.
Several other HER2-based targeting treatments have been developed based on modified nanocarriers to improve the therapeutic efficacy of specific antineoplastic agents. For example, one recent study discussed the development of trastuzumab conjugated pH-sensitive double-emulsion nanocapsules (DENCs) that are stabilized by both poly (vinyl alcohol) and magnetic nanoparticles. In this work, the researchers used these nanocarriers for the co-delivery of doxorubicin (DOX) and paclitaxel, which were found to improve the targeting ability of these drugs towards HER2 positive breast cancer cells.
The first FDA-approved nanodrug was Doxil®, which is a PEGylated liposomal DOX formulation that passively targets tumors via the enhanced permeability and retention (EPR) effect. Importantly, Doxil® is associated with significantly reduced cardiotoxicity as compared to when DOX is used alone.
Challenges
Despite the numerous advantages associated with both INPs and organic nanoparticles as drug delivery vehicles, several major challenges still account for their limited clinical use. One of the most significant issues includes the regulatory mechanisms currently in place for nanomedicines and the safety and toxicity assessments that need to be better tailored for nanomedical applications….
News
Scientists Just Captured the Stunning Process That Shapes Chromosomes
Scientists at EMBL have captured how human chromosomes fold into their signature rod shape during cell division, using a groundbreaking method called LoopTrace. By observing overlapping DNA loops forming in high resolution, they revealed that large [...]
Bird Flu Virus Is Mutating Fast – Scientists Say Our Vaccines May Not Be Enough
H5N1 influenza is evolving rapidly, weakening the effectiveness of existing antibodies and increasing its potential threat to humans. Scientists at UNC Charlotte and MIT used high-performance computational modeling to analyze thousands of viral protein-antibody interactions, revealing [...]
Revolutionary Cancer Vaccine Targets All Solid Tumors
The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer. Cancer treatment vaccines have been in development since 2010, when the first was approved for prostate cancer, followed [...]
Scientists Uncover Hidden Protein Driving Autoimmune Attacks
Scientists have uncovered a critical piece of the puzzle in autoimmune diseases: a protein that helps release immune response molecules. By studying an ultra-rare condition, researchers identified ArfGAP2 as a key player in immune [...]
Mediterranean neutrino observatory sets new limits on quantum gravity
Quantum gravity is the missing link between general relativity and quantum mechanics, the yet-to-be-discovered key to a unified theory capable of explaining both the infinitely large and the infinitely small. The solution to this [...]
Challenging Previous Beliefs: Japanese Scientists Discover Hidden Protector of Heart
A Japanese research team found that the oxidized form of glutathione (GSSG) may protect heart tissue by modifying a key protein, potentially offering a novel therapeutic approach for ischemic heart failure. A new study [...]
Millions May Have Long COVID – So Why Can’t They Get Diagnosed?
Millions of people in England may be living with Long Covid without even realizing it. A large-scale analysis found that nearly 10% suspect they might have the condition but remain uncertain, often due to [...]
Researchers Reveal What Happens to Your Brain When You Don’t Get Enough Sleep
What if poor sleep was doing more than just making you tired? Researchers have discovered that disrupted sleep in older adults interferes with the brain’s ability to clean out waste, leading to memory problems [...]
How to prevent chronic inflammation from zombie-like cells that accumulate with age
In humans and other multicellular organisms, cells multiply. This defining feature allows embryos to grow into adulthood, and enables the healing of the many bumps, bruises and scrapes along the way. Certain factors can [...]
Breakthrough for long Covid patients who lost sense of smell
A breakthrough nasal surgery has restored the sense of smell for a dozen long Covid patients. Experts at University College London Hospitals NHS Foundation Trust successfully employed a technique typically used for correcting blocked nasal passages, [...]
Scientists Invent Plastic That Can Dissolve In Seawater In Just A Few Hours
Plastic waste and pollution in the sea have been among the most serious environmental problems for decades, causing immense damage to marine life and ecosystems. However, a breakthrough discovery may offer a game-changing solution. [...]
Muscles from the 3D printer
Swiss researchers have developed a method for printing artificial muscles out of silicone. In the future, these could be used on both humans and robots. Swiss researchers have succeeded in printing artificial muscles out [...]
Beneficial genetic changes observed in regular blood donors
Researchers at the Francis Crick Institute have identified genetic changes in blood stem cells from frequent blood donors that support the production of new, non-cancerous cells. Understanding the differences in the mutations that accumulate [...]
Shocking Amounts of Microplastics in the Brain – It Could Be Increasing Our Risk of Dementia
The brain has higher concentrations of plastic particles compared to other organs, with increased levels found in dementia patients. In a comprehensive commentary published in Brain Medicine, researchers highlight alarming new evidence of microplastic accumulation [...]
Baffling Scientists for Centuries: New Study Unravels Mystery of Static Electricity
ISTA physicists demonstrate that contact electrification depends on the contact history of materials. For centuries, static electricity has intrigued and perplexed scientists. Now, researchers from the Waitukaitis group at the Institute of Science and [...]
Tumor “Stickiness” – Scientists Develop Potential New Way To Predict Cancer’s Spread
UC San Diego researchers have developed a device that predicts breast cancer aggressiveness by measuring tumor cell adhesion. Weakly adherent cells indicate a higher risk of metastasis, especially in early-stage DCIS. This innovation could [...]
